Abstract
The insulin-like growth factor 1 (IGF1) receptor is closely related to the insulin receptor. However, the unique biological functions of IGF1 receptor make it a target for therapeutic intervention in human cancer. Using its isolated tyrosine kinase domain, we show that the IGF1 receptor is regulated by intermolecular autophosphorylation at three sites within the kinase activation loop. Steady-state kinetic analyses of the isolated phosphorylated forms of the IGF1 receptor kinase (IGF1RK) reveal that each autophosphorylation event increases enzyme turnover number and decreases Km for ATP and peptide. We have determined the 2.1 Å-resolution crystal structure of the tris-phosphorylated form of IGF1RK in complex with an ATP analog and a specific peptide substrate. The structure of IGF1RK reveals how the enzyme recognizes peptides containing hydrophobic residues at the P+1 and P+3 positions and how autophosphorylation stabilizes the activation loop in a conformation that facilitates catalysis. Although the nucleotide binding cleft is conserved between IGF1RK and the insulin receptor kinase, sequence differences in the nearby interlobe linker could potentially be exploited for anticancer drug design.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams, T.E., Epa, V.C., Garrett, T.P.J. & Ward, C.W. Cell. Mol. Life Sci. 57, 1050–1093 (2000).
Lui, J.P., Baker, J., Perkins, A.S., Robertson, E.J. & Efstratiadis, A. Cell 75, 59–72 (1993).
Baserga, R., Hongo, A., Rubini, M., Prisco, M. & Valentinis, B. Biochim. Biophys. Acta. 1332, 105–126 (1997).
Yarden, Y. & Ullrich, A. Biochemistry 27, 3113–3119 (1988).
Hubbard, S.R. & Till, J.H. Annu. Rev. Biochem. 69, 373–398 (2000).
Blakesley, V.A., Scrimgeour, A., Esposito, D. & LeRoith, D. Cytokine Growth Factor Rev. 7, 153–159 (1996).
Ullrich, A. et al. EMBO J. 5, 2503–2512 (1986).
Lamothe, B. et al. Biochem. J. 335, 193–204 (1998).
Urso, B. et al. J. Biol. Chem. 274, 30864–30873 (1999).
Patti M.E. & Kahn C.R. J. Basic Clin. Physiol. Pharmacol. 9, 89–109 (1998).
Lammers, R., Gray, A., Schlessinger, J. & Ullrich, A. EMBO J. 8, 1369–1375 (1989).
Kato, H., Faria, T.N., Stannard, B., Roberts, C.T. Jr., & LeRoith, D. J. Biol. Chem. 268, 2655–2661 (1993).
Murakami, M.S. & Rosen, O.M. J. Biol. Chem. 266, 22653–22660 (1991).
Wei, L., Hubbard, S.R., Hendrickson, W.A. & Ellis, L. J. Biol. Chem. 270, 8122–8130 (1995).
Butler, A.A. et al. Comp. Biochem. Physiol. 121, 19–26 (1998).
Hubbard, S.R., Wei, L., Ellis, L. & Hendrickson, W.A. Nature 372, 746–754 (1994).
Hubbard, S.R. EMBO J. 16, 5572–5581 (1997).
Gruppuso, P.A., Boylan, J.M., Levine, B.A. & Ellis, L. Biochem. Biophys. Res. Comm. 189, 1457–1463 (1992).
Al-Hasani, H., Passlack, W. & Klein, H.W. FEBS Lett. 349, 17–22 (1994).
Barker, S.C. et al. Biochemistry 34, 14843–14851 (1995).
Porter, M., Schindler, T., Kuriyan, J. & Miller, W.T. J. Biol. Chem. 275, 2721–2726 (2000).
Moarefi, I. et al. Nature 385, 650–653 (1997).
Songyang, Z. et al. Nature 373, 536–539 (1995).
Ablooglu, A.J. & Kohanski, R.A. Biochemistry 40, 504–513 (2001).
Xu, B., Bird, V.G. & Miller, W.T. J. Biol. Chem. 270, 29825–29830 (1995).
Mohammadi, M. et al. Science 276, 955–960 (1997).
Mohammadi, M. et al. EMBO J. 17, 5896–5904 (1998).
Schindler, T. et al. Science 289, 1938–1942 (2000).
Zhu, X. et al. Structure Fold. Des. 7, 651–661 (1999).
Blum, G., Gazit, A. & Levitzki, A. Biochemistry 39, 15705–15712 (2000).
Parang K. et al. Nature Struct. Biol. 8, 37–41 (2001).
Otwinowski, Z. in Proceedings of the CCP4 study weekend (eds. Sawyer, L., Isaacs, N. & Baily, S.) 6–62 (SERC Daresbury Laboratory, Daresbury, UK; 1993).
Navaza, J. Acta Crystallogr. A 50, 157–163 (1994).
Peitsch, M.C. Biochem. Soc. Trans. 24, 274–279 (1996).
Brünger, A.T. et al. Acta Crystallogr. D 54, 905–921 (1998).
Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Acta Crystallogr. A 47, 110–119 (1991).
Acknowledgements
This work was supported by grants from the NIH to S.R.H. and to W.T.M. Beamline X4A at the National Synchrotron Light Source, a DOE facility, is supported by the Howard Hughes Medical Institute.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Favelyukis, S., Till, J., Hubbard, S. et al. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Mol Biol 8, 1058–1063 (2001). https://doi.org/10.1038/nsb721
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsb721
This article is cited by
-
Transactivation of receptor tyrosine kinases by purinergic P2Y and adenosine receptors
Purinergic Signalling (2023)
-
Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study
Molecular Diversity (2023)
-
14-3-3β is essential for milk composition stimulated by Leu/IGF-1 via IGF1R signaling pathway in BMECs
In Vitro Cellular & Developmental Biology - Animal (2022)
-
Increased O-GlcNAcylation promotes IGF-1 receptor/PhosphatidyI Inositol-3 kinase/Akt pathway in cervical cancer cells
Scientific Reports (2022)
-
IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation
Nature Communications (2021)